MedTech Terms
    The authoritative reference
    All terms

    Management Review

    Top-management evaluation of QMS performance at planned intervals.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    ISO 13485 clause 5.6 and 21 CFR 820.20 require top management to review the QMS at defined intervals, evaluating audit results, customer feedback, process performance, CAPA, and the need for resources or improvement.
    What the regulation says
    Management review is a mandatory activity for medical device manufacturers, as stipulated by regulations like 21 CFR 820.20(c) from the FDA and standards such as ISO 13485:2016 clause 5.6. These reviews ensure the continuing suitability, adequacy, and effectiveness of the Quality Management System (QMS). The reviews must include assessing opportunities for improvement and the need for changes to the QMS, including the quality policy and quality objectives.

    What this means in practice

    Management reviews should produce documented decisions and actions. Inspectors often request meeting minutes and follow-up evidence.

    Examples

    • A MedTech company reviews its QMS annually, where top management examines internal audit reports, customer complaint trends, and production output data to decide on resource allocation for new equipment.
    • During a management review, a manufacturer identifies a recurring issue with product non-conformities and decides to initiate a corrective action plan, including retraining production staff.
    • Following new regulatory updates, a management review meeting assesses the impact on the QMS and approves changes to design control procedures to maintain compliance with EU MDR Annex I.
    Common pitfalls
    • Failing to document management review outputs, including decisions and actions, can lead to audit findings.
    • Not involving appropriate top management personnel in the review process undermines its effectiveness and regulatory compliance.
    • Conducting reviews as a mere formality, without genuine critical evaluation and follow-up on identified actions, is a common pitfall.
    • Excluding crucial inputs, such as audit results, customer feedback, or process performance data, can result in an incomplete and ineffective review.
    • Delaying or omitting corrective and preventive actions (CAPA) identified during management review can lead to systemic quality issues and regulatory non-compliance.

    Frequently asked questions

    The primary purpose is to ensure the ongoing suitability, adequacy, and effectiveness of the Quality Management System, identifying opportunities for improvement and necessary changes.

    Cross-references

    Follows

    Comes after in a typical workflow or lifecycle.

    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    ISO·1AAMI·1MDIC·1
    1. 1
      ISO 13485:2016
      Verified
      ISOiso.org
    2. 2
      AAMI - Quality Systems Resources
      Verified
      AAMIaami.org
    3. 3
      MDIC Case for Quality
      Verified
      MDICmdic.org

    Inline markers like [1] jump to the matching reference above.